Tender detail

Open-house medicine discount agreements for rituximab

Summary

AOK Bayern intends to conclude non-exclusive discount agreements with pharmaceutical companies for medicines containing the active ingredient rituximab (ATC L01FA01). The agreements will start no earlier than 1 December 2026 and remain in force until 30 November 2028.

Reference number
cf6a8398-fdaf-4fd5-8fda-8a7901fefd6f
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-10-03
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.